URN:NBN:SI:doc-WM3ZV7M32024Lunder, Mojcadocuments/doc/W/URN_NBN_SI_doc-WM3ZV7M3_001.pdfdocuments/doc/W/URN_NBN_SI_doc-WM3ZV7M3_001.txt275articlestr. 130-1360014-8229196225795URN:NBN:SI:doc-WM3ZV7M3slvSlovensko farmacevtsko društvoFarmacevtski vestnikInCaducanumabadukanumabAlzheimer’s diseaseAlzheimerjeva bolezenbiological drugsBiološka zdravilalecanemablekanemabmonoclonal antibodiesmonoklonska protitelesaBiopharmaceuticals for Alzheimer’s diseaseBiološke učinkovine pri Alzheimerjevi bolezni